国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2011年
15期
1867-1870
,共4页
冠心病%糖尿病%辛伐他汀%丹参注射液
冠心病%糖尿病%辛伐他汀%丹參註射液
관심병%당뇨병%신벌타정%단삼주사액
Coronary heart disease%Diabetes mellitus%Simvastatin%Salvia miltiorrhiza injections
目的 探讨辛伐他汀联合丹参注射液治疗冠心病合并糖尿病的临床疗效.方法 将114例冠心病合并糖尿病患者随机分为两组,对照组57例采用常规治疗,加用辛伐他汀,观察组57例则在对照组的基础上加用丹参注射液,两组连续治疗3个月,比较两组心功能改善、心绞痛发作、血清超氧化物歧化酶(SOD)、丙二醛(MDA)和空腹血糖含量以及不良反应发生情况.结果 观察组总有效率为94.74%,对照组为80.70%,两组相比差异有统计学意义(P<0.05);观察组患者治疗后心绞痛发作频率、心绞痛持续时间和硝酸甘油用量较对照组均明显下降,两组相比差异有统计学意义(P<0.05);治疗后两组患者血清SOD含量上升,MDA含量下降,观察组血清SOD含量较对照组明显上升幅度更加明显(P<0.05);两组空腹血糖治疗前后比较,差异无统计学意义(P>0.05),无明显不良反应发生.结论 辛伐他汀联合丹参注射液治疗冠心病合并糖尿病能明显改善心功能,减少心绞痛的发作频率、心绞痛持续时间和硝酸甘油用量,有效地降低冠心病合并糖尿病患者的血脂水平.
目的 探討辛伐他汀聯閤丹參註射液治療冠心病閤併糖尿病的臨床療效.方法 將114例冠心病閤併糖尿病患者隨機分為兩組,對照組57例採用常規治療,加用辛伐他汀,觀察組57例則在對照組的基礎上加用丹參註射液,兩組連續治療3箇月,比較兩組心功能改善、心絞痛髮作、血清超氧化物歧化酶(SOD)、丙二醛(MDA)和空腹血糖含量以及不良反應髮生情況.結果 觀察組總有效率為94.74%,對照組為80.70%,兩組相比差異有統計學意義(P<0.05);觀察組患者治療後心絞痛髮作頻率、心絞痛持續時間和硝痠甘油用量較對照組均明顯下降,兩組相比差異有統計學意義(P<0.05);治療後兩組患者血清SOD含量上升,MDA含量下降,觀察組血清SOD含量較對照組明顯上升幅度更加明顯(P<0.05);兩組空腹血糖治療前後比較,差異無統計學意義(P>0.05),無明顯不良反應髮生.結論 辛伐他汀聯閤丹參註射液治療冠心病閤併糖尿病能明顯改善心功能,減少心絞痛的髮作頻率、心絞痛持續時間和硝痠甘油用量,有效地降低冠心病閤併糖尿病患者的血脂水平.
목적 탐토신벌타정연합단삼주사액치료관심병합병당뇨병적림상료효.방법 장114례관심병합병당뇨병환자수궤분위량조,대조조57례채용상규치료,가용신벌타정,관찰조57례칙재대조조적기출상가용단삼주사액,량조련속치료3개월,비교량조심공능개선、심교통발작、혈청초양화물기화매(SOD)、병이철(MDA)화공복혈당함량이급불량반응발생정황.결과 관찰조총유효솔위94.74%,대조조위80.70%,량조상비차이유통계학의의(P<0.05);관찰조환자치료후심교통발작빈솔、심교통지속시간화초산감유용량교대조조균명현하강,량조상비차이유통계학의의(P<0.05);치료후량조환자혈청SOD함량상승,MDA함량하강,관찰조혈청SOD함량교대조조명현상승폭도경가명현(P<0.05);량조공복혈당치료전후비교,차이무통계학의의(P>0.05),무명현불량반응발생.결론 신벌타정연합단삼주사액치료관심병합병당뇨병능명현개선심공능,감소심교통적발작빈솔、심교통지속시간화초산감유용량,유효지강저관심병합병당뇨병환자적혈지수평.
Objective To explore the efficacy of simvastatin combined with salvia miltiorrhiza injections for coronary heart disease ( CHD ) concurrent with diabetes mellitus ( DM ). Methods 114 patients with CHD concurrent with DM were randomly assigned to receive conventional therapy plus simvastatin ( 57 patients,control group ), or conventional treatment plus simvastatin and salvia miltiorrhiza injections ( 57 patients, study group ) for three months. The improvement in heart function, angina peetoris attacks, serum levels of superoxide dismutases ( SOD ) and malondialdehyde ( MDA ), fast blood glucose level, and incidence of adverse reactions were compared between the two groups. Results The total effectiveness rate differed significantly between the study group and the control group ( 94.74% vs. 80.70%, P < 0.05 ). As compared with those in the control group, the frequency of angina pectoris attacks, duration of angina, and nitroglycerin use were significantly declined in the study group after treatment ( P< 0.05 ). Serum SOD level increased while MDA level decreased in both groups the SOD level elevated more markedly in the study than in the control group ( P< 0.05 ). There was no significant difference in fast blood glucose level after treatment ( P> 0.05 ). No obvious adverse reactions were found. Conclusions Combination therapy with simvastatin and salvia miltiorrhiza injections can improve heart function, reduce frequency of angina pectoris attacks and nitroglycerin use, shorten duration of angina, and effectively lower blood lipid level in patients with coronary heart disease concurrent with diabetes mellitus.